The Permanente journal · 2025
Proteinuria Screening in the Primary Care Office: A Review and a Quality Improvement Project.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Khil Jaclyn, Sundang Alvina, Zheng Sijie
Аннотация
BACKGROUND: Proteinuria is associated with substantial cardiovascular and renal morbidity, mortality, and increased rates of hospitalization. It serves as an early indicator of chronic kidney disease (CKD).
OBJECTIVES: This review examined the relationship between proteinuria, CKD, and major adverse cardiovascular events, summarized evidence-based therapies, identified gaps in screening, and presented a quality improvement (QI) project from Kaiser Permanente East Bay.
METHODS: The authors conducted a literature review and a QI project using the Kaiser Permanente national CKD staging algorithm. Patients aged 18-75 years old with CKD stages 3 or 4 were identified and categorized by comorbidities. Screening rates were analyzed.
RESULTS: All patients with diabetes and CKD 3 and 4 received proteinuria screening. Screening rates were lower among patients with hypertension and without diabetes.
CONCLUSIONS: Early detection and intervention can reduce major adverse cardiovascular events and CKD progression. The QI project highlights effective workflows and the need to expand screening protocols to broader populations.
OBJECTIVES: This review examined the relationship between proteinuria, CKD, and major adverse cardiovascular events, summarized evidence-based therapies, identified gaps in screening, and presented a quality improvement (QI) project from Kaiser Permanente East Bay.
METHODS: The authors conducted a literature review and a QI project using the Kaiser Permanente national CKD staging algorithm. Patients aged 18-75 years old with CKD stages 3 or 4 were identified and categorized by comorbidities. Screening rates were analyzed.
RESULTS: All patients with diabetes and CKD 3 and 4 received proteinuria screening. Screening rates were lower among patients with hypertension and without diabetes.
CONCLUSIONS: Early detection and intervention can reduce major adverse cardiovascular events and CKD progression. The QI project highlights effective workflows and the need to expand screening protocols to broader populations.